Abstract:

Objective To explore the clinical eff ect of surgical treatment of breast fi broadenoma through areola incision. Method 70 female patients with breast fi broadenoma admitted to Taizhou People’s Hospital from May 2022 to April 2024 were selected and randomly divided into a study group and a control group, with 35 cases in each group. The control group underwent traditional breast fi broadenoma resection, while the study group under-went areola incision breast fi broadenoma resection. The perioperative conditions, postoperative incision recovery, quality of life, as well as complications and recurrence were compared between the two groups of patients. Result The intraoperative blood loss and length of hospital stay in the study group were less than those in the control group, and the incision length was shorter than that in the control group; And the total eff ective rate of the study group patients was 97.14%, signifi cantly higher than the control group (82.86%), with signifi cant diff erences (P ＜ 0.05). The Vancouver Scar Scale score and European Organization for Research and Treatment Quality of Life Questionnaire score of patients in the study group were signifi cantly lower than those in the control group at 1 and 3 months after surgery. The incidence of complications and recurrence rate of patients in the study group were 2.86% (1/35) and 0, respectively, which were signifi cantly lower than those in the control group [17.14% (6/35) and 11.43% (4/35), respectively], and the diff erences were signifi cant (P ＜ 0.05). Conclusion The application of the areola incision for breast fi broadenoma resection has a signifi cant therapeutic eff ect, which is benefi cial for reducing damage, accelerating recovery, improving aesthetics, and enhancing patients’ quality of life.

Key words: Fibroadenoma of the breast, Incision through the areola, Curative eff ect